Urinary excretion of apolipoprotein(a): relation to other plasma proteins

被引:6
作者
Kostner, K
Spitzauer, S
Rumpold, H
Maurer, G
Knipping, G
Hrzenjak, A
Frank, S
Kostner, GM
机构
[1] AKH Vienna, Univ Hosp, Dept Cardiol, A-1090 Vienna, Austria
[2] AKH Vienna, Univ Hosp, Dept Clin Chem, A-1090 Vienna, Austria
[3] Graz Univ, Inst Med Biochem, A-8010 Graz, Austria
关键词
atherosclerosis; ApoD; beta(2)-glycoprotein-I; orosomucoid; catabolism;
D O I
10.1016/S0009-8981(00)00394-6
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
The atherogenic lipoprotein Lp(a) consists of an LDL-like core and apo(a). linked to apoB via a thiol bridge. Apo(a) fragments ranging in size from 60 to 220 kDa are excreted into urine and the excretion rate correlates significantly with the plasma levels of Lp(a). In order to study the interrelationship of apo(a) secretion with that of other plasma proteins. urinary apo(a) and protein secretion of five probands were followed for 24 h at different urinary densities. The excretion rate of apo(a) fragments, despite their high molecular weight, was highest. followed by apoD. orosomucoid. albumin and beta (2)-glycoprotein-I (beta2-GI) and plasminogen (1.58, 0.87, 0.095, 0.027, 0.013 and <0.001%/day, respectively). There was a highly significant correlation between apo(a). apoD and <beta>2-GI concentrations but not with albumin and orosomucoid concentrations in urine. The only protein that was fragmented in urine was apo(a) while the other proteins had molecular weights comparable to those in plasma. We conclude that a previously suggested fragmentation of apo(a) by the kidney is not a rate-limiting step in its excretion. Since plasminogen. another kringle-IV-containing plasma compound, and fragments thereof, are undetectable in urine under identical experimental conditions. it is very unlikely that the characteristic kringle structure is responsible for the high excretion rate of apo(a). (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:29 / 37
页数:9
相关论文
共 26 条
[1]  
AUSTIN MA, 1992, AM J HUM GENET, V51, P829
[2]  
Berg K, 1997, CLIN GENET, V52, P254
[3]  
BERG K, 1974, CLIN GENET, V6, P230
[4]   Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger - A prospective study [J].
Bostom, AG ;
Cupples, LA ;
Jenner, JL ;
Ordovas, JM ;
Seman, LJ ;
Wilson, PWF ;
Schaefer, EJ ;
Castelli, WP .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (07) :544-548
[5]  
Böttcher A, 2000, J LIPID RES, V41, P905
[6]   Urinary excretion of apo(a) fragments in NIDDM patients [J].
Clodi, M ;
Oberbauer, R ;
Waldhausl, W ;
Maurer, G ;
Kostner, GM .
DIABETOLOGIA, 1997, 40 (12) :1455-1460
[7]   LIPOPROTEIN LP(A) AS PREDICTOR OF MYOCARDIAL-INFARCTION IN COMPARISON TO FIBRINOGEN - LDL CHOLESTEROL AND OTHER RISK-FACTORS - RESULTS FROM THE PROSPECTIVE GOTTINGEN RISK INCIDENCE AND PREVALENCE STUDY (GRIPS) [J].
CREMER, P ;
NAGEL, D ;
LABROT, B ;
MANN, H ;
MUCHE, R ;
ELSTER, H ;
SEIDEL, D .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1994, 24 (07) :444-453
[8]  
Edelstein C, 1996, J LIPID RES, V37, P1786
[9]  
FRANK F, 1997, PROT ENG, V10, P297
[10]   COMPARATIVE-ANALYSIS OF THE APO(A) GENE, APO(A) GLYCOPROTEIN, AND PLASMA-CONCENTRATIONS OF LP(A) IN 3 ETHNIC-GROUPS - EVIDENCE FOR NO COMMON LP(A) ALLELE AT THE APO(A) LOCUS [J].
GAW, A ;
BOERWINKLE, E ;
COHEN, JC ;
HOBBS, HH .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (06) :2526-2534